FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:535-536 February 14, 2002 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: The report by Manges et al. (Oct. 4 issue)¹ regarding the widespread distribution of multidrug-resistant Escherichia coli is both important and timely. We have found even higher rates of resistance to trimethoprim–sulfamethoxazole (TMP-SMX) among E. coli and other organisms at Elmhurst Hospital in Queens, New York. This hospital serves an incredibly diverse immigrant population that includes large numbers of people from Asia and Latin America. As part of a quality-improvement project, we reviewed more than 900 positive urine cultures that had been obtained since October 1998; approximately 40 percent were resistant to TMP-SMX. The majority of our . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Colgan, R., Johnson, J. R., Kuskowski, M., Gupta, K. (2008). Risk Factors for Trimethoprim-Sulfamethoxazole Resistance in Patients with Acute Uncomplicated Cystitis. Antimicrob. Agents Chemother. 52: 846-851 [Abstract] [Full Text]